Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 144

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 144
---
 after the Keystone Commencement Date, at no cost or penalty, upon one trading days’ prior written notice to Keystone, provided that we shall have issued all Keystone Commitment Shares to Keystone prior to such termination. We and Keystone may also terminate the Keystone Purchase Agreements at any time by mutual written consent. Keystone also has the right to terminate the Keystone Purchase Agreements upon 10 trading days’ prior written notice to us, but only upon the occurrence of certain customary events as listed in the Keystone Purchase Agreements. No termination of the Keystone Purchase Agreements by us or by Keystone will become effective prior to the first trading day immediately following the date on which any pending Purchase has been fully settled in accordance with the terms and conditions of the Keystone Purchase Agreements, and will not affect any of our respective rights and obligations under the Keystone Purchase Agreements with respect to any pending Purchase, and both we and Keystone have agreed to complete our respective obligations with respect to any such pending Purchase under the Keystone Purchase Agreements. Prohibition of “Dilutive Issuances” During Pending Purchases Subject to certain exceptions, during any Reference Period (as defined in the Keystone Purchase Agreements) with respect to a Purchase, we are limited in our ability to issue any Common Stock, or any securities convertible into Common Stock, at an effective price per share of Common Stock less than the applicable Purchase Price to be sold to Keystone in the applicable Purchase to which such Reference Period relates. No Short-Selling or Hedging Each Selling Securityholder has agreed that neither it nor any entity managed or controlled by it, will engage in, directly or indirectly, any (i) “short sale” (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii) hedging transaction, which, with respect to items (i) and (ii), establishes a net short position with respect to the Common Stock, during the term of the Keystone Purchase Agreements. Effect of Sales of our Common Stock under the Keystone Purchase Agreements on our Stockholders The Common Stock being registered for resale in this offering may be issued and sold by us to the Selling Securityholder from time to time at our discretion, during the terms described above. The resale by the Selling Securityholder of a significant quantity of shares registered for resale in this offering at any given time, or the perception that these sales may occur, could cause the market price of our Common Stock to decline and to be highly volatile. Sales of our Common Stock, if any